From June 19th to 21st, 2024, the 22nd China International Pharmaceutical Ingredients Exhibition (CPHI China 2024) was held at the Shanghai New International Expo Centre in Pudong, Shanghai. The exhibition scale reached over 210,000㎡, and nearly 3,500 well-known enterprises at home and abroad participated in the exhibition with their products and technologies. As a veteran pharmaceutical enterprise that has been deeply engaged in the R&D and production services of the entire pharmaceutical industrial chain for more than 10 years, Vcare PharmaTech has been present at the CPHI exhibition for 10 consecutive years.
At this CPHI exhibition, Nanjing Vcare together with its affiliated production base, Tianshu Pharmaceutical, made a wonderful appearance in Hall W3 (Comprehensive Area of Pharmaceutical Ingredients). The new products such as characteristic active pharmaceutical ingredients, advanced pharmaceutical intermediates, customized chemicals, as well as new R&D achievements and the R&D and supply services covering the whole CRO/CDMO industrial chain on display attracted high attention and recognition from domestic and foreign customers. The booth of Nanjing Vcare Pharmaceutical Co., Ltd. received nearly 400 new and old customers from dozens of countries. They exchanged information, held docking and negotiation talks, and deeply discussed the development prospects of the pharmaceutical industry and the layout and planning of the one-stop CRO/CDMO service model. Intentions of cooperation were reached on the spot with most of these customers, which also laid a good foundation for further strengthening contacts and in-depth cooperation.
Efficient, Flexible and High-Quality One-Stop CDMO Solutions
Nanjing Vcare Pharmaceutical Co., Ltd. owns a 21,000-square-meter high-end pharmaceutical R&D center and a production base covering an area of 130 mu located in a provincial-level chemical industrial park in Hubei Province. Its CDMO services feature a leading technical level, sufficient production capacity, strong delivery ability and a sound quality system. It has mastered the following core technologies:
Cryogenic reactions, reactions between organolithium and electrophilic reagents; Asymmetric hydrogenation reactions, asymmetric hydrogenation of carbonyl groups and double bonds; Metal-catalyzed construction of carbon-heteroatom bonds such as C-N and C-O; Construction of common heterocycles, such as indazole, indole, pyrimidine, etc.; Amide condensation reactions; Reduction reactions of carbonyl groups or imines; Continuous flow nitration reactions; Reactions for oxidizing hydroxyl groups to aldehydes or acids based on continuous flow.
Pharmaceutical Services: Building a One-Stop Empowerment Platform to Make Drug R&D "More, Faster, Better and Cheaper"
The pharmaceutical services provided by Nanjing Vcare cover pharmaceutical R&D and registration as well as associated supply of intermediates and active pharmaceutical ingredients. Adhering to the concept of "leaving the complexity to ourselves and the simplicity to our customers", it focuses on building a one-stop empowerment platform to provide customers with innovative drug and generic drug development services quickly and with high quality. Its pharmaceutical services have differentiated advantages such as the guarantee of the whole industrial chain service model, the guarantee of the whole-process quality system and the guarantee of high-quality project management.
More than 10 clinical approvals for innovative drugs; More than 30 production approvals for generic drugs; More than 60 items in the process of registration and declaration; Helped customers win bids in the centralized procurement for nearly 10 approved varieties; Supporting products for over 3,000 items in the innovative drug catalogue; Supporting products for over 300 intermediates and over 2,000 impurities in the generic drug catalogue.
Adhering to Green, Environmental Protection and Safety, Supplying Dozens of Characteristic Active Pharmaceutical Ingredients and Over a Hundred Advanced Pharmaceutical Intermediates
The chemical services of Nanjing Vcare have always adhered to green, environmental protection and safety, and always adhered to the core concepts of "transforming chemical production with science and technology" and "producing chemicals with the attitude of drug development". It has introduced industry-leading continuous flow reaction engineering technology, bio-enzyme engineering technology, preparative separation engineering technology, etc., and provides R&D, industrialization and sales services for characteristic active pharmaceutical ingredients and key intermediates. At present, it has gradually built a product library covering dozens of characteristic active pharmaceutical ingredients, over a hundred advanced pharmaceutical intermediates and nearly a thousand supporting impurities.
Talent Concept
Recruitment
Follow Us
